Home » PAR PHARMACEUTICAL ANNOUNCES PRODUCT COLLABORATION WITH SPECTRUM PHARMACEUTICALS, INC.
PAR PHARMACEUTICAL ANNOUNCES PRODUCT COLLABORATION WITH SPECTRUM PHARMACEUTICALS, INC.
Par Pharmaceutical Companies, Inc. today announced that it has entered into
a collaborative agreement with Spectrum Pharmaceuticals, Inc. to develop and
market generic drugs, including generic versions of injectable and ophthalmic
pharmaceuticals. Spectrum, located in Irvine, California, is a specialty pharmaceutical
company that develops both proprietary and generic drugs.
PR
Newswire
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May